Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.verified

SRPT

Price:

$120.66

Market Cap:

$11.53B

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping. The company is also developing AMONDYS 45, a product candidate that uses phosphorodiamidate morpholino oligomer chemistry and exon-skipping tech...[Read more]

Industry

Biotechnology

IPO Date

1997-06-04

Stock Exchange

NASDAQ

Ticker

SRPT

The Current Ratio as of December 2024 (TTM) for Sarepta Therapeutics, Inc. (SRPT) is 3.84

According to Sarepta Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.84. This represents a change of -2.39% compared to the average of 3.93 of the last 4 quarters.

Sarepta Therapeutics, Inc. (SRPT) Historical Current Ratio (quarterly & annually)

How has SRPT Current Ratio performed in the past?

The mean historical Current Ratio of Sarepta Therapeutics, Inc. over the last ten years is 6.27. The current 3.84 Current Ratio has changed 6.02% with respect to the historical average. Over the past ten years (40 quarters), SRPT's Current Ratio was at its highest in in the December 2017 quarter at 13.91. The Current Ratio was at its lowest in in the June 2016 quarter at 2.29.

Quarterly (TTM)
Annual

Average

6.27

Median

5.65

Minimum

3.60

Maximum

13.91

Sarepta Therapeutics, Inc. (SRPT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sarepta Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 180.89%

Maximum Annual Current Ratio = 13.91

Minimum Annual Increase = -46.37%

Minimum Annual Current Ratio = 3.60

Quarterly (TTM)
Annual
YearCurrent RatioChange
20233.95-4.41%
20224.13-28.23%
20215.75-3.71%
20205.977.67%
20195.55-32.43%
20188.21-40.97%
201713.91180.89%
20164.9537.38%
20153.60-46.37%
20146.72-10.73%

Sarepta Therapeutics, Inc. (SRPT) Average Current Ratio

How has SRPT Current Ratio performed in the past?

The current Current Ratio of Sarepta Therapeutics, Inc. (SRPT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.61

5-year avg

5.07

10-year avg

6.27

Sarepta Therapeutics, Inc. (SRPT) Current Ratio vs. Peers

How is SRPT’s Current Ratio compared to its peers?

Sarepta Therapeutics, Inc.’s Current Ratio is less than Reata Pharmaceuticals, Inc. (6.75), less than Mirati Therapeutics, Inc. (7.54), less than Krystal Biotech, Inc. (7.97), less than Intercept Pharmaceuticals, Inc. (4.22), greater than PTC Therapeutics, Inc. (2.10), less than Iovance Biotherapeutics, Inc. (4.22), less than Madrigal Pharmaceuticals, Inc. (5.98), less than Viking Therapeutics, Inc. (36.47), greater than Hepion Pharmaceuticals, Inc. (1.30), less than Terns Pharmaceuticals, Inc. (0), less than Akero Therapeutics, Inc. (32.99), less than null (17.25),

Build a custom stock screener for Sarepta Therapeutics, Inc. (SRPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sarepta Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sarepta Therapeutics, Inc. (SRPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sarepta Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Sarepta Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Sarepta Therapeutics, Inc. (SRPT)?

What is the highest Current Ratio for Sarepta Therapeutics, Inc. (SRPT)?

What is the 3-year average Current Ratio for Sarepta Therapeutics, Inc. (SRPT)?

What is the 5-year average Current Ratio for Sarepta Therapeutics, Inc. (SRPT)?

How does the current Current Ratio for Sarepta Therapeutics, Inc. (SRPT) compare to its historical average?